Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice

Area of Science:

• Biochemistry
• Molecular Biology
• Hepatology

Background:

• Vitamin D receptor (VDR) plays a crucial role in regulating bile acid metabolism and detoxification pathways.
• Lithocholic acid (LCA), a toxic secondary bile acid, can cause severe liver damage (hepatotoxicity) when accumulated.
• Cytochrome P450 3A4 (CYP3A4) is a key enzyme in drug and bile acid metabolism, and is a target gene of VDR.

Purpose of the Study:

• To investigate the protective role of intestinal cytochrome P450 3A4 (CYP3A4) against lithocholic acid (LCA)-induced hepatotoxicity in the context of vitamin D receptor (VDR) deficiency.
• To elucidate the mechanisms by which intestinal CYP3A4 influences bile acid metabolism and detoxification.

Main Methods:

• Generation of a mouse model with intestine-specific VDR disruption (Vdr(ΔIEpC)) and subsequent insertion of the CYP3A4 gene (Vdr(ΔIEpC)/3A4).
• Administration of LCA to control, Vdr(ΔIEpC), and Vdr(ΔIEpC)/3A4 mice.
• Measurement of hepatic toxicity (necrosis, inflammation) and quantification of bile acid levels in various tissues (liver, intestine, bile, urine).

Main Results:

• VDR deficiency in the intestine exacerbates LCA-induced hepatotoxicity, leading to increased liver necrosis and inflammation due to bile acid accumulation.
• Intestinal expression of CYP3A4 in Vdr(ΔIEpC)/3A4 mice significantly reduced LCA-induced hepatotoxicity.
• CYP3A4 expression led to enhanced LCA metabolism and detoxification, and suppressed bile acid transporter expression in the small intestine.

Conclusions:

• Intestinal CYP3A4 provides a critical protective mechanism against hepatotoxicity induced by toxic bile acids like LCA.
• VDR signaling and intestinal CYP3A4 activity are integral to maintaining bile acid homeostasis and preventing liver injury.
• Targeting intestinal CYP3A4 could be a therapeutic strategy for managing bile acid-related liver diseases.